The federal government will extend COVID-era telehealth flexibilities until December 2024, dramatically extending the runway for the Drug Enforcement Administration (DEA) to establish new rules for using telehealth and controlled substances. The DEA and U.S. Department of Health and Human Services released a new temporary rule on Oct. 6 after conducting two days of listening sessions about how best to regulate telehealth and controlled substances in the post-COVID era. The DEA expects to release a new rule regulating telehealth and controlled substances in about a year.
Read the full article: DEA Extends Telehealth Flexibilities Another Year //
Source: https://bhbusiness.com/2023/10/06/dea-extends-telehealth-flexibilities-another-year